Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Mortality
[105] RCT	5926 people with vascular disease who were intolerant to ACE inhibitors	Cardiovascular mortality 227/2954 (7.7%) with telmisartan 223/2972 (7.5%) with placebo	HR 1.03 95% CI 0.85 to 1.24 P = 0.78		Not significant